Response Genetics Inc (OTC Pink - No Information:RGDXQ)

0.0021
Delayed Data
As of May 22
 -0.0001 / -4.55%
Today’s Change
0.00
Today|||52-Week Range
0.01
+200.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$182.3K

Company Description

Response Genetics, Inc. engages in the research and development of clinical diagnostic tests for cancer. Its platforms include analysis of single biomarkers using the polymerase chain reaction method as well as global gene interrogation using microarray methods from paraffin or frozen tissue specimens. It also provides pharmacogenomic testing services of clinical trial specimens to pharmaceutical companies. The company was founded by David A. Smith and Kathleen Danenberg on September 23, 1999 and is headquartered in Los Angeles, CA.

Contact Information

Response Genetics, Inc.
1640 Marengo Street
Los Angeles California 90033-1036
P:(323) 224-3900
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Kevin Roy HarrisChief Financial Officer, Director & Vice President